Tabular baseline patient characteristics |
Age [y] |
Cont. |
79.8 ± 7.6 |
0.2% |
82.2 ± 6.8 |
0.2% |
Aortic regurgitation [severity score between 0 and 3] |
Cont. |
0.66 ± 0.70 |
13.0% |
0.67 ± 0.70 |
21.1% |
Aortic valve area [] |
Cont. |
0.77 ± 0.20 |
12.2% |
0.76 ± 0.21 |
20.6% |
Body mass index [] |
Cont. |
27.2 ± 4.8 |
0.4% |
26.4 ± 4.8 |
0.2% |
Cerebrovascular disease |
Binary |
0.18 |
0.6% |
0.19 |
0.3% |
Chronic obstructive pulmonary disease |
Binary |
0.13 |
1.0% |
0.18 |
0.8% |
Coronary artery bypass grafting |
Binary |
0.19 |
2.6% |
0.21 |
0.6% |
Coronary atheromatosis or stenosis |
Binary |
0.69 |
44.3% |
0.78 |
15.6% |
Creatinine [ mol/L] |
Cont. |
99.7 ± 54.0 |
10.1% |
121.6 ± 84.3 |
5.3% |
Diabetes mellitus |
Binary |
0.23 |
2.1% |
0.27 |
0.8% |
Dyslipidemia |
Binary |
0.61 |
1.8% |
0.51 |
1.7% |
Family history of any cardiovascular disease |
Binary |
0.26 |
8.7% |
0.33 |
2.7% |
Glomerular filtration rate [mL/min/] |
Cont. |
59.7 ± 19.6 |
1.0% |
53.5 ± 21.9 |
1.9% |
Hemoglobin [g/L] |
Cont. |
124.2 ± 18.9 |
10.7% |
118.0 ± 19.0 |
5.5% |
Hypertension |
Binary |
0.80 |
1.5% |
0.81 |
0.5% |
Left ventricular ejection fraction [%] |
Cont. |
55.0 ± 12.8 |
9.2% |
53.1 ± 13.9 |
18.2% |
Male |
Binary |
0.52 |
0.5% |
0.53 |
0.3% |
Mean transaortic pressure gradient [mmHg] |
Cont. |
42.3 ± 15.7 |
9.0% |
40.7 ± 16.1 |
17.6% |
Mitral regurgitation [severity score between 0 and 3] |
Cont. |
0.92 ± 0.78 |
15.7% |
1.14 ± 0.84 |
24.4% |
Pacemaker at baseline |
Binary |
0.95 |
1.8% |
0.89 |
8.3% |
Peripheral artery disease |
Binary |
0.18 |
0.9% |
0.27 |
0.3% |
Previous cardiovascular interventions |
Binary |
0.23 |
3.6% |
0.17 |
0.8% |
Renal replacement or dialysis |
Binary |
0.01 |
11.4% |
0.05 |
5.2% |
Smoking status |
Binary |
0.29 |
39.6% |
0.33 |
9.6% |
Valve in valve |
Binary |
0.05 |
0% |
0.02 |
0.2% |
Preprocedural 3D torso CT image |
CT image |
Cont. |
– |
58.1% |
– |
37.1% |
CT image measurements |
Agatston score aortic valve |
Cont. |
2787.0 ± 1821.4 |
28.9% |
2715.0 ± 1675.9 |
14.9% |
Area-derived diameter of annulus incl. calcification [mm] |
Cont. |
24.2 ± 4.0 |
6.6% |
24.6 ± 2.8 |
8.0% |
Area of annulus incl. calcification [] |
Cont. |
460.5 ± 97.5 |
6.6% |
479.7 ± 107.0 |
8.0% |
Calcification of ascending aorta |
Cont. |
1.9 ± 1.7 |
41.0% |
1.9 ± 0.8 |
16.0% |
Calcification of sinotubular junction |
Cont. |
1.1 ± 0.8 |
61.4% |
1.1 ± 0.8 |
37.4% |
Diameter of ascending aorta [mm] |
Cont. |
35.1 ± 4.3 |
6.0% |
34.8 ± 4.2 |
7.7% |
LVOT area [] |
Cont. |
433.1 ± 111.6 |
6.9% |
450.2 ± 117.9 |
7.2% |
LVOT maximal diameter [mm] |
Cont. |
28.2 ± 3.4 |
5.7% |
28.5 ± 3.9 |
7.2% |
Maximal annulus diameter [mm] |
Cont. |
27.4 ± 3.0 |
6.4% |
27.9 ± 3.1 |
8.0% |
Maximal diameter of sinotubular junction [mm] |
Cont. |
29.2 ± 3.6 |
6.8% |
29.3 ± 3.7 |
8.0% |
Perimeter of annulus incl. calcification [mm] |
Cont. |
77.2 ± 8.4 |
6.5% |
79.3 ± 8.7 |
8.0% |
Sinus portion maximal diameter [mm] |
Cont. |
32.5 ± 4.0 |
7.0% |
33.2 ± 3.9 |
7.9% |
Volume of sinus valsalva [] |
Cont. |
23.3 ± 9.7 |
45.1% |
17.7 ± 7.2 |
36.5% |
Volume score aortic valve |
Cont. |
1180.5 ± 926.8 |
57.7% |
967.6 ± 736.8 |
37.3% |
Volume score LVOT |
Cont. |
36.6 ± 85.7 |
13.2% |
52.4 ± 108.7 |
10.1% |
Outcome |
Death during follow-up |
Binary |
– |
0% |
– |
0% |